D.E. Shaw & Co’s Yarrow Bioscience YARW Stock Holding History

D.E. Shaw & Co’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8	Closed	-$231K	–	4007
2018 Q2	$231K	Buy	+8	New	+$311K	﹤0.01%	3491

Other funds holding YARW

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co's YARW Position: Q3 2018 in Review

D.E. Shaw & Co sold out of Yarrow Bioscience (YARW) in Q3 2018, closing a stake of 8 shares — an estimated $231K sold.

D.E. Shaw & Co first reported a position in YARW in Q2 2018 and held it in 1 quarter. The position peaked at $231K in Q2 2018. 42 funds tracked by Wall St. Rank hold YARW as of Q3 2018.

D.E. Shaw & Co reported no remaining Yarrow Bioscience position as of Q3 2018 after selling out during the quarter.
D.E. Shaw & Co sold 8 Yarrow Bioscience shares in Q3 2018, an estimated $231K.
D.E. Shaw & Co first reported a position in Yarrow Bioscience in Q2 2018 and held it in 1 quarter.
D.E. Shaw & Co's Yarrow Bioscience position peaked at $231K in Q2 2018.
42 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2018.

Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.